BofA Global Research cuts CVS Health price objective to $100 from $110
CVS•BofA Global Research cut its price objective for CVS Health to $100 from $110.
Related News
WW Grainger: Stephens raises target price to $1,380 from $1,355
GWW•
Oscar Health beats Q3 revenue estimates, raises 2026 outlook
OSCR•
Leerink Partners cuts Veracyte to Market Perform from Outperform, target to $35 from $55
VCYT•
South Bow Corp.: Barclays raises target price to C$48 from C$47
SOBO•
Mosaic price objective cut to $23 from $26 by BofA Global Research
MOS•